Kingsview Wealth Management LLC Boosts Holdings in Corteva, Inc. $CTVA

Kingsview Wealth Management LLC raised its position in shares of Corteva, Inc. (NYSE:CTVA) by 238.6% in the third quarter, Holdings Channel reports. The firm owned 47,372 shares of the company’s stock after acquiring an additional 33,383 shares during the quarter. Kingsview Wealth Management LLC’s holdings in Corteva were worth $3,204,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. Total Investment Management Inc. purchased a new stake in shares of Corteva during the second quarter valued at approximately $27,000. Activest Wealth Management lifted its position in Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after acquiring an additional 200 shares in the last quarter. True Wealth Design LLC boosted its stake in Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after purchasing an additional 264 shares during the last quarter. Twin Peaks Wealth Advisors LLC bought a new stake in shares of Corteva in the 2nd quarter worth $29,000. Finally, Redmont Wealth Advisors LLC purchased a new position in shares of Corteva in the third quarter worth $29,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Performance

CTVA stock opened at $77.98 on Thursday. The firm has a market cap of $52.44 billion, a P/E ratio of 49.35, a P/E/G ratio of 2.70 and a beta of 0.72. The stock’s 50 day simple moving average is $72.63 and its 200 day simple moving average is $68.97. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12-month low of $53.40 and a 12-month high of $80.90.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. During the same quarter in the previous year, the firm earned $0.32 earnings per share. The firm’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s payout ratio is presently 45.57%.

Analyst Upgrades and Downgrades

CTVA has been the topic of several recent analyst reports. Wolfe Research increased their price objective on Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Rothschild & Co Redburn reduced their price target on shares of Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a research note on Tuesday, November 11th. Wells Fargo & Company increased their price objective on shares of Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Royal Bank Of Canada lifted their target price on shares of Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Finally, BNP Paribas Exane increased their price target on Corteva from $70.00 to $72.00 and gave the company a “neutral” rating in a report on Monday, November 17th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, Corteva has an average rating of “Moderate Buy” and an average price target of $82.80.

Insider Activity at Corteva

In other news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider directly owned 8,090 shares in the company, valued at approximately $619,289.50. This represents a 50.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.14% of the company’s stock.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.